Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Getz JA"'
Autor:
Wu KC; Department of Safety Assessment, Genentech Inc., South San Francisco, CA 94080, United States of America., Adedeji AO; Department of Safety Assessment, Genentech Inc., South San Francisco, CA 94080, United States of America., Zabka TS; Department of Safety Assessment, Genentech Inc., South San Francisco, CA 94080, United States of America., Hosseini I; Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., South San Francisco, CA 94080, United States of America., Kenkre R; Department of Preclinical and Translational Pharmacokinetics and Pharmacodynamics, Genentech Inc., South San Francisco, CA 94080, United States of America., Getz JA; Department of Bioanalytical Sciences, Genentech Inc., South San Francisco, CA 94080, United States of America., Nguyen T; Department of Safety Assessment, Genentech Inc., South San Francisco, CA 94080, United States of America., Decalf J; Department of Cancer Immunology, Genentech Inc., South San Francisco, CA 94080, United States of America., Bainbridge TW; Department of Protein Chemistry, Genentech Inc., South San Francisco, CA 94080, United States of America., Chilton JA; Charles River Laboratories, Reno, NV 89511, United States of America., Moussion CC; Department of Cancer Immunology, Genentech Inc., South San Francisco, CA 94080, United States of America., Rao GK; Department of Safety Assessment, Genentech Inc., South San Francisco, CA 94080, United States of America. Electronic address: rao.gautham@gene.com.
Publikováno v:
Toxicology and applied pharmacology [Toxicol Appl Pharmacol] 2024 Feb; Vol. 483, pp. 116837. Date of Electronic Publication: 2024 Jan 24.
Autor:
Getz JA; Bioanalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA., Nguy T; Bioanalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA., Dere R; Bioanalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA., Maia M; Bioanalytical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, CA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2024; Vol. 16 (8), pp. 239-247. Date of Electronic Publication: 2024 Mar 20.
Autor:
Adedeji AO; Genentech, South San Francisco, California, USA., Zhong F; Genentech, South San Francisco, California, USA., Getz JA; Genentech, South San Francisco, California, USA., Zhong Z; Genentech, South San Francisco, California, USA., Halpern W; Genentech, South San Francisco, California, USA.
Publikováno v:
Toxicologic pathology [Toxicol Pathol] 2022 Dec; Vol. 50 (8), pp. 910-919. Date of Electronic Publication: 2022 Nov 03.
Autor:
Ullman JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Arguello A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bhalla A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wang J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Blumenfeld JR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ravi R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nugent AA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Davis SS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ha C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Duque J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tran HL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Lianoglou S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Daryani VM; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nguyen H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Earr T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dugas JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tuck MD; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Harvey JL; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Reyzer ML; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Caprioli RM; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Poda S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Gunasekaran K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sandmann T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Di Paolo G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Astarita G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Diaz D; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com., Henry AG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Autor:
Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tong R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Assimon VA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chen X; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zhang Y; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Jenkins K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kane L; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Miyamoto T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chew KS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Pizzo ME; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Calvert MEK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., DeVos SL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Baskaran S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zuchero YJY; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Autor:
Henriques ST; Institute for Molecular Bioscience, The University of Queensland, Brisbane, Queensland, Australia., Thorstholm L, Huang YH, Getz JA, Daugherty PS, Craik DJ
Publikováno v:
PloS one [PLoS One] 2013 Nov 15; Vol. 8 (11), pp. e80474. Date of Electronic Publication: 2013 Nov 15 (Print Publication: 2013).
Autor:
Getz JA; Department of Chemical Engineering, University of California , Santa Barbara, California 93106, United States., Cheneval O, Craik DJ, Daugherty PS
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2013; Vol. 8 (6), pp. 1147-54. Date of Electronic Publication: 2013 Apr 12.
Autor:
Jabaiah AM; Department of Chemical Engineering, University of California, Santa Barbara, CA 93106, USA., Getz JA, Witkowski WA, Hardy JA, Daugherty PS
Publikováno v:
Biological chemistry [Biol Chem] 2012 Sep; Vol. 393 (9), pp. 933-41.
Autor:
Erster O; Department of Chemical Engineering, University of California, Santa Barbara, CA 93106, USA., Thomas JM, Hamzah J, Jabaiah AM, Getz JA, Schoep TD, Hall SS, Ruoslahti E, Daugherty PS
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2012 Aug 10; Vol. 161 (3), pp. 804-12. Date of Electronic Publication: 2012 May 23.
Autor:
Getz JA; Department of Chemical Engineering, Institute for Collaborative Biotechnologies, University of California, Santa Barbara, California, USA., Schoep TD, Daugherty PS
Publikováno v:
Methods in enzymology [Methods Enzymol] 2012; Vol. 503, pp. 75-97.